Learn / Stock guides / ABBV

NYSE: ABBV

AbbVie (ABBV) stock, explained like you're 5

AbbVie trades on the New York Stock Exchange under the ticker ABBV. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 464.3 billion dollars.

Ticker
ABBV
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Drug Manufacturers General
Size
Mega cap, about 464.3 billion dollars

How AbbVie makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ABBV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy? (Yahoo Finance)
  • AbbVie Tokenized Stock price today, ABBVX to USD chart, marketcap and volume (CryptoSlate)
  • AbbVie Stock: Buy, Sell, or Hold in October? (The Motley Fool)
  • AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval (Simply Wall Street)
  • If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today (Benzinga)

Follow ABBV in your daily brief

Each trading day at 5 PM ET we post what happened to AbbVie and why it matters, in plain English. Free.

Start my free brief

Key terms to know before you follow ABBV

Questions about AbbVie stock

What does AbbVie do?

AbbVie trades on the New York Stock Exchange under the ticker ABBV. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 464.3 billion dollars.

What is the ticker symbol for AbbVie?

AbbVie trades under the ticker ABBV on the New York Stock Exchange.

How does AbbVie make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ABBV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ABBV stock every day?

Add ABBV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in plain English.

Similar stocks

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.